Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

BACKGROUND. Older patients (≥60 years) with acute myeloid leukemia (AML) face difficult decisions regarding treatment with “intensive” chemotherapy that carries significant toxicity for a small chance of a cure versus “nonintensive” chemotherapy to control the disease, but with fewer side effects. H...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: El‐Jawahri, Areej, Nelson‐Lowe, Margaret, VanDusen, Harry, Traeger, Lara, Abel, Gregory A., Greer, Joseph A., Fathi, Amir, Steensma, David P., LeBlanc, Thomas W., Li, Zhigang, DeAngelo, Daniel, Wadleigh, Martha, Hobbs, Gabriela, Foster, Julia, Brunner, Andrew, Amrein, Philip, Stone, Richard M., Temel, Jennifer S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2018
Pynciau:
Symptom Management and Supportive Care
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369944/
https://ncbi.nlm.nih.gov/pubmed/30139841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0317
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg